PL429033A1 - Protein-sugar fraction isolated from the coelomic fluid of Dendrobaena veneta earthworm for application in non-specific immunotherapy - Google Patents

Protein-sugar fraction isolated from the coelomic fluid of Dendrobaena veneta earthworm for application in non-specific immunotherapy

Info

Publication number
PL429033A1
PL429033A1 PL429033A PL42903319A PL429033A1 PL 429033 A1 PL429033 A1 PL 429033A1 PL 429033 A PL429033 A PL 429033A PL 42903319 A PL42903319 A PL 42903319A PL 429033 A1 PL429033 A1 PL 429033A1
Authority
PL
Poland
Prior art keywords
protein
earthworm
specific immunotherapy
application
fraction isolated
Prior art date
Application number
PL429033A
Other languages
Polish (pl)
Other versions
PL238444B1 (en
Inventor
Magdalena Mizerska-Kowalska
Barbara Zdzisińska
Marta Fiołka
Katarzyna Musiał
Original Assignee
Uniwersytet Marii Curie-Skłodowskiej
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Uniwersytet Marii Curie-Skłodowskiej filed Critical Uniwersytet Marii Curie-Skłodowskiej
Priority to PL429033A priority Critical patent/PL238444B1/en
Publication of PL429033A1 publication Critical patent/PL429033A1/en
Publication of PL238444B1 publication Critical patent/PL238444B1/en

Links

Landscapes

  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Przedmiotem wynalazku jest wysokocząsteczkowa frakcja białkowo-cukrowa wyizolowana z płynu celomatycznego dżdżownicy Dendrobaena veneta o masie cząsteczek powyżej 14 kDa, znajdująca nowe zastosowanie w immunoterapii nieswoistej jako aktywator ludzkich makrofagów do zwiększonego wydzielania jednych z najważniejszych i działających wielokierunkowo działających cytokin IL-6 i IL-1ß.The subject of the invention is a high molecular weight protein-sugar fraction isolated from the cellomatous fluid of Dendrobaena veneta with a molecular weight above 14 kDa, finding a new application in non-specific immunotherapy as an activator of human macrophages for increased secretion of one of the most important and multidirectional cytokines IL-6 and IL-1ß .

PL429033A 2019-02-25 2019-02-25 Protein-sugar fraction isolated from the coelomic fluid of Dendrobaena veneta earthworm for application in non-specific immunotherapy PL238444B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
PL429033A PL238444B1 (en) 2019-02-25 2019-02-25 Protein-sugar fraction isolated from the coelomic fluid of Dendrobaena veneta earthworm for application in non-specific immunotherapy

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PL429033A PL238444B1 (en) 2019-02-25 2019-02-25 Protein-sugar fraction isolated from the coelomic fluid of Dendrobaena veneta earthworm for application in non-specific immunotherapy

Publications (2)

Publication Number Publication Date
PL429033A1 true PL429033A1 (en) 2020-09-07
PL238444B1 PL238444B1 (en) 2021-08-23

Family

ID=72291425

Family Applications (1)

Application Number Title Priority Date Filing Date
PL429033A PL238444B1 (en) 2019-02-25 2019-02-25 Protein-sugar fraction isolated from the coelomic fluid of Dendrobaena veneta earthworm for application in non-specific immunotherapy

Country Status (1)

Country Link
PL (1) PL238444B1 (en)

Also Published As

Publication number Publication date
PL238444B1 (en) 2021-08-23

Similar Documents

Publication Publication Date Title
MX2021013662A (en) HETEROARYLAMINOPYRIMIDINE AMIDE AUTOPHAGY INHIBITORS AND METHODS OF USE OF THESE.
DK202300015Y9 (en) Non-animal based protein sources with functional properties
MX2020008772A (en) Il-15 conjugates and uses thereof.
WO2021127487A3 (en) Novel il2 agonists and methods of use thereof
MX2021014443A (en) Tead inhibitors and uses thereof.
MY193351A (en) Anti-vegf protein compositions and methods for producing the same
PH12021551534A1 (en) Antibody against human il-4ra and use thereof
WO2020006385A3 (en) Compositions and methods for modulating monocyte and macrophage inflammatory phenotypes and immunotherapy uses thereof
MY207121A (en) Anti-ror antibody constructs
EP4501952A3 (en) Conjugated hepcidin mimetics
DK202300014Y9 (en) Protein compositions and consumable products thereof
MX2017014730A (en) Muteins of human lipocalin 2 with affinity for glypican-3 (gpc3).
MX2023014154A (en) ANTI-CCR8 ANTIBODIES.
CL2022001185A1 (en) Therapeutic derivatives of interleukin-22
CO2022009737A2 (en) Anti-ly6g6d antibodies and methods of use
AR106981A1 (en) AN ANTIMICROBIAL COMPOSITION
BR112021013206A2 (en) Peptide libraries and respective methods of use
MX2021006922A (en) Multigene construct for immune-modulatory protein expression and methods of use.
PL429033A1 (en) Protein-sugar fraction isolated from the coelomic fluid of Dendrobaena veneta earthworm for application in non-specific immunotherapy
EA202092963A1 (en) NEW PROTEIN WITH ANTI-INFLAMMATORY PROPERTIES
MY194322A (en) Methods of determining interferon having direct inhibitory effects on tumors and uses thereof
MX2021002013A (en) Methods of determining protein or peptide concentration and uses thereof.
HUE062455T2 (en) Protein secretion inhibitors based on triazacyclododecanesulfonamide ("TCD").
CL2020003220A1 (en) New protein with anti-inflammatory properties
MX2021015879A (en) RESTRICTED PEPTIDES.